Fox Run Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Sell |
11,267
-18,700
| -62% | -$262K | 0.03% | 774 |
|
|
2025
Q1 | $469K | Buy |
29,967
+13,021
| +77% | +$204K | 0.07% | 523 |
|
|
2024
Q4 | $236K | Sell |
16,946
-2,384
| -12% | -$33.2K | 0.04% | 715 |
|
|
2024
Q3 | $180K | Sell |
19,330
-9,509
| -33% | -$88.4K | 0.04% | 683 |
|
|
2024
Q2 | $268K | Buy |
+28,839
| New | +$268K | 0.05% | 580 |
|
|
2023
Q4 | – | Sell |
-11,216
| Closed | -$59.6K | – | 719 |
|
|
2023
Q3 | $59.6K | Buy |
+11,216
| New | +$59.6K | 0.02% | 656 |
|